Gemina Laboratories Ltd.
GLABF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Market Cap | $47,321 | $40,880 | $42,040 | $25,431 |
| - Cash | $1 | $1 | $83 | $1,156 |
| + Debt | $1,274 | $485 | $241 | $46 |
| Enterprise Value | $48,594 | $41,365 | $42,198 | $24,321 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$113 | -$93 | -$50 | -$44 |
| % Margin | – | – | – | – |
| EBITDA | -$3,796 | -$5,176 | -$5,930 | -$4,691 |
| % Margin | – | – | – | – |
| Net Income | -$4,074 | -$5,217 | -$5,979 | -$4,735 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.055 | -0.072 | -0.099 | -0.099 |
| % Growth | 23.6% | 27.5% | 0.1% | – |
| Operating Cash Flow | -$1,301 | -$3,244 | -$4,510 | -$3,872 |
| Capital Expenditures | $0 | -$41 | -$80 | -$10 |
| Free Cash Flow | -$1,301 | -$3,285 | -$4,589 | -$3,882 |